LINC01571

Across TCGA pan-cancer cohorts, LINC01571 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of LINC01571’s most consistent transcriptional readouts.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where LINC01571 RNA is repressed in tumor relative to normal tissue. In most cancer types LINC01571 is over-expressed in tumor, although a few such as KIRC and THCA show the opposite, repressed pattern.

KIRC, THCA, and KICH are the cancer types where LINC01571 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in LINC01571 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
KIRC	Male	II,III,IV	−2.715	<.001	12	view →
THCA	Male	All	−2.309	<.001	11	view →
KICH	Male	All	−3.910	<.001	10	view →
KIRP	Male	III,IV	−2.345	<.001	9	view →
LUSC	Female	All	−1.122	<.001	8	view →
LUAD	Female	All	−0.939	<.001	8	view →
COAD	All	IV	−0.635	<.001	8	view →
READ	All	II,III,IV	−0.620	<.001	7	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

LINC01571–KIRC

Open the KIRC breakdown →